# Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients

> **NCT00228436** · PHASE2 · COMPLETED · sponsor: **Affymax** · enrollment: 139 (actual)

## Conditions studied

- Anemia
- Chronic Kidney Disease
- Chronic Renal Failure

## Interventions

- **DRUG:** peginesatide

## Key facts

- **NCT ID:** NCT00228436
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2012-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00228436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00228436, "Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00228436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*